261 related articles for article (PubMed ID: 6896534)
1. Changes of plasma 6-keto-PGF1 alpha and thromboxane B2 levels and platelet aggregation after tourniquet ischemia on the upper limb in normal subjects and patients with ischemic heart disease.
Chen LS; Ito T; Ogawa K; Satake T
Jpn Circ J; 1982 Jul; 46(7):651-6. PubMed ID: 6896534
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of 6-keto-prostaglandin F1 alpha, thromboxane B2 and platelet aggregation in patients with essential hypertension.
Chen LS; Ito T; Ogawa K; Shikano M; Satake T
Jpn Heart J; 1984 Nov; 25(6):1001-9. PubMed ID: 6549401
[TBL] [Abstract][Full Text] [Related]
3. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
Ylikorkala O; Mäkilä UM; Viinikka L
Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
[TBL] [Abstract][Full Text] [Related]
4. [Plasma level and effects of thromboxane A2 and 6-keto-PGF1 alpha in patients with acute obstructive suppurative cholangitis].
Miao XY
Zhonghua Wai Ke Za Zhi; 1990 Apr; 28(4):228-30, 253-4. PubMed ID: 2379443
[TBL] [Abstract][Full Text] [Related]
5. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
Shikano M; Ito T; Ogawa K; Satake T
Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
[TBL] [Abstract][Full Text] [Related]
6. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans.
Ylikorkala O; Puolakka J; Viinikka L
Am J Obstet Gynecol; 1982 Mar; 142(5):573-6. PubMed ID: 7036746
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
8. 6-Keto prostaglandin F1 alpha, thromboxane B2 and 13,14-dihydro-15-keto prostaglandin F levels in maternal and fetal plasma.
Yamaguchi M; Mori N
Prostaglandins Leukot Med; 1984 Sep; 15(3):325-36. PubMed ID: 6593746
[TBL] [Abstract][Full Text] [Related]
9. The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stress.
Mehta J; Mehta P; Horalek C
Am Heart J; 1983 Jun; 105(6):895-900. PubMed ID: 6344604
[TBL] [Abstract][Full Text] [Related]
10. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease].
Liu H; Chen Z; Gao R
Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):595-8. PubMed ID: 8697924
[TBL] [Abstract][Full Text] [Related]
11. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
12. [Changes in platelet aggregation, TXB2 and 6-keto-PGF1 alpha in surgical shock].
Tian L
Zhonghua Wai Ke Za Zhi; 1990 Jun; 28(6):339-41, 381. PubMed ID: 2096057
[TBL] [Abstract][Full Text] [Related]
13. The concentrations of 6-keto-PGF1 alpha and TXB2 in plasma samples from patients with benign and malignant tumours of the breast.
Nigam S; Becker R; Rosendahl U; Hammerstein J; Benedetto C; Barbero M; Slater TF
Prostaglandins; 1985 Apr; 29(4):513-28. PubMed ID: 3839084
[TBL] [Abstract][Full Text] [Related]
14. Evidence for isosorbide dinitrate (ISDN) promoting effect on prostacyclin release by the lung and prostacyclin implication in ISDN-induced inhibition of platelet aggregation in humans.
Rolland PH; Bory M; Leca F; Sainsous J; Gueydon E; Juhan I; Serradimigni A; Cano JP
Prostaglandins Leukot Med; 1984 Dec; 16(3):333-46. PubMed ID: 6396656
[TBL] [Abstract][Full Text] [Related]
15. Some interrelationships between glucose levels thromboxane production and prostacyclin production in normal and diabetic mice.
Rosenblum WI; Hirsh PD
Prostaglandins; 1984 Jan; 27(1):111-8. PubMed ID: 6546804
[TBL] [Abstract][Full Text] [Related]
16. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog.
Prosdocimi M; Finesso M; Gorio A; Languino LR; Del Maschio A; Castagnoli MN; De Gaetano G; Dejana E
Am J Physiol; 1985 Apr; 248(4 Pt 2):H493-9. PubMed ID: 3838623
[TBL] [Abstract][Full Text] [Related]
17. Reduction of prostacyclin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery.
Tada M; Esumi K; Yamagishi M; Kuzuya T; Matsuda H; Abe H; Uchida Y; Murao S
J Mol Cell Cardiol; 1984 Dec; 16(12):1137-49. PubMed ID: 6398370
[TBL] [Abstract][Full Text] [Related]
18. Plasma thromboxane B2, 6-keto PGF1 alpha and cyclic nucleotides levels as related to treadmill exercise test in patients with ischemic heart disease.
Yajima M; Nomura S; Namba K; Sekine M; Hosaka T; Numano F
Jpn Circ J; 1985 Jan; 49(1):38-45. PubMed ID: 2982050
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
[TBL] [Abstract][Full Text] [Related]
20. [A study of the role of plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha in epidemic hemorrhagic fever].
Wang GQ; Zou ZZ; Yu DP
Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):138-40, 188. PubMed ID: 1976492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]